← Back

$ Value

$0

Shares

22,000

Price

$0

Filed

Feb 24

Insider

Name

Cvijic Christine Mikail

Title

President and CFO

CIK

0001543663

Roles

Officer

Transaction Details

Transaction Date

2026-02-20

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

114,643

Footnotes

Consist of 22,000 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date. | Includes (a) 21,269 restricted stock units remaining from a grant of 31,900 restricted stock units granted on March 13, 2024 that vest annually in equal installments on March 13, 2025, March 13, 2026 and March 13, 2027; (b) 20,300 restricted stock units granted on March 26, 2025, which will vest annually in equal installments on March 26, 2026, March 26, 2027 and March 26, 2028; and (c) 22,000 restricted stock units granted on February 20, 2026, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029. Of the remaining shares, 24,000 are held jointly by the reporting person and her spouse, David Cvijic. | This option represents the right to purchase 131,900 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date.

Filing Info

Accession No.

0001543663-26-000002

Form Type

4

Issuer CIK

0001404644

Cvijic Christine Mikail's History

Date Ticker Type Value
2026-03-26 NGNE $55K
2026-03-13 NGNE $49K
2026-03-13 NGNE $30K
2026-03-13 NGNE $6K
2026-02-27 NGNE $121K
2026-02-20 NGNE A $0
2026-02-20 NGNE A $0

Other Insiders at NGNE (90d)

Insider Bought Sold Last
BAFFI ROBERT 2026-02-20
PALEKAR ROHAN 2026-02-20
Cvijic Christine Mikail
President and CFO
$260K 2026-03-26
McMinn Rachel
Chief Executive Officer
$74K 2026-03-26
Noonberg Sarah B. 2026-02-20
Freedland Cory S. 2026-02-20
Jordan Julie
Chief Medical Officer
$18K 2026-03-26
Cobb Stuart
Chief Scientific Officer
$141K 2026-03-13
Woods Keith 2026-02-20